IL2 and neoplasm: In tumours, however, binding of PD-L1 to its PD-1 receptor on activated T cells results in T-cell suppression and immune escape by inhibiting perforin/granzyme production, suppressing IL-2 and IFN-γ production and promoting apoptosis, effectively inducing tumour growth (37).